Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 13, 2022

SELL
$193.77 - $244.14 $194,932 - $245,604
-1,006 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$223.92 - $287.77 $45,455 - $58,417
203 Added 25.28%
1,006 $241,000
Q3 2021

Nov 12, 2021

BUY
$282.99 - $369.05 $227,240 - $296,347
803 New
803 $227,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $21.4B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Engine No. 1 LLC Portfolio

Follow Engine No. 1 LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Engine No. 1 LLC, based on Form 13F filings with the SEC.

News

Stay updated on Engine No. 1 LLC with notifications on news.